Skip to content
Clinical Trials – home

Bacterial prostatitis Treatment

3 / 3 trials open to patients2 countries

In short

Bacterial prostatitis occurs when bacteria invade the prostate gland, causing infection, inflammation, and a range of uncomfortable urinary and pelvic symptoms. Though it represents a smaller portion of all prostatitis cases, proper diagnosis and timely treatment with antibiotics can make a significant difference in recovery and preventing complications.

Key points

  • Bacterial prostatitis is caused by bacterial infection and represents about ten percent of all prostatitis cases, with E. coli being the most common culprit.
  • Acute bacterial prostatitis is a medical emergency that comes on suddenly with fever, chills, and severe urinary symptoms requiring immediate antibiotic treatment.
  • Fluoroquinolone antibiotics like ciprofloxacin are the standard treatment, typically taken for four to six weeks, sometimes extending to twelve weeks for best results.
  • Completing the full antibiotic course is essential even when you feel better, as stopping early can lead to chronic infection that's much harder to cure.
  • Hospitalization with IV antibiotics may be necessary for severe cases, especially when fever is high, urination is impossible, or sepsis is a concern.
  • Alpha-blocker medications can help relieve urinary symptoms by relaxing prostate and bladder muscles, and are often used alongside antibiotics.
  • Chronic bacterial prostatitis can develop in about five percent of men after acute infection and may require extended or repeated antibiotic courses.
  • Growing antibiotic resistance, particularly after prostate procedures, is making some infections harder to treat and may require alternative antibiotics.

Understanding Treatment Goals for Bacterial Prostatitis

When bacteria infect the prostate gland, the primary goal of treatment is to eliminate the infection, relieve uncomfortable symptoms, and prevent the condition from becoming chronic or causing serious complications. The treatment approach depends heavily on whether the infection is acute, meaning it comes on suddenly with severe symptoms, or chronic, meaning it develops gradually and persists over months.

Acute bacterial prostatitis is considered a medical emergency that requires immediate attention. Men with this condition often experience high fever, chills, body aches, and severe difficulty urinating. Without prompt treatment, the infection can spread to the bloodstream, a life-threatening situation known as sepsis, which occurs when the body's response to infection causes widespread inflammation.

Chronic bacterial prostatitis, on the other hand, develops more slowly and may cause milder symptoms that come and go over time. However, it can be stubborn and difficult to cure completely, sometimes requiring extended courses of antibiotics. About five percent of men who experience acute bacterial prostatitis may go on to develop the chronic form if the initial infection is not completely eradicated.

Treatment decisions also depend on the patient's overall health, age, and whether there are complicating factors such as an enlarged prostate, weakened immune system, or recent medical procedures involving the urinary tract. Medical societies and healthcare guidelines recommend specific antibiotics and treatment durations based on extensive clinical research and experience.

Standard Treatment for Bacterial Prostatitis

Antibiotic Therapy

Antibiotics form the cornerstone of treatment for bacterial prostatitis because bacteria are the direct cause of the infection. The choice of antibiotic depends on several factors, including which bacteria are causing the infection, how severe the symptoms are, and whether the infection is acute or chronic.

For acute bacterial prostatitis, doctors most commonly prescribe medications from a class called fluoroquinolones, which are antibiotics particularly effective against bacteria that commonly infect the prostate. The most frequently used fluoroquinolone is ciprofloxacin, though levofloxacin is also preferred by some clinicians. These medications work by interfering with bacterial DNA, preventing the bacteria from multiplying and ultimately killing them.

Men with acute bacterial prostatitis typically need to take antibiotics for two to six weeks. This longer duration is necessary because antibiotics must penetrate the prostate tissue, where the infection resides, and the prostate can be difficult for medications to reach effectively. Taking the full course of antibiotics is essential, even if symptoms improve earlier, to ensure all bacteria are eliminated and prevent the development of antibiotic-resistant strains.

In severe cases of acute bacterial prostatitis, especially when a patient has high fever, appears very ill, cannot urinate, or cannot keep down oral medications, hospitalization becomes necessary. In the hospital, antibiotics are given directly into a vein through an intravenous (IV) line, allowing higher concentrations of the medication to reach the bloodstream quickly. Common IV antibiotics include combinations such as ceftriaxone with doxycycline, or piperacillin/tazobactam. Once the patient stabilizes and fever subsides, treatment can usually continue with oral antibiotics at home.

Chronic bacterial prostatitis requires even longer antibiotic treatment, typically lasting at least two to six weeks, but sometimes extending up to twelve weeks. Because this form of the infection tends to recur, some men may need repeated courses of antibiotics or even long-term, low-dose antibiotic therapy to keep the infection under control.

The bacteria most often responsible for prostatitis infections is Escherichia coli (commonly called E. coli), which normally lives in the intestines. This bacterium accounts for fifty to ninety percent of bacterial prostatitis cases. Other bacteria that can cause the infection include Pseudomonas aeruginosa, and species of Klebsiella, Enterococcus, Enterobacter, Proteus, and Serratia. In younger, sexually active men, sexually transmitted infections such as Neisseria gonorrhoeae (gonorrhea) and Chlamydia trachomatis can also cause prostatitis.

Healthcare providers use urine cultures to identify which specific bacteria are causing the infection. This laboratory test involves collecting a urine sample and growing any bacteria present on special plates to see which antibiotics will be most effective against them. This process, called antibiotic sensitivity testing, helps doctors choose the right medication for each individual patient.

Additional Medications for Symptom Relief

Beyond antibiotics, several other medications help manage the uncomfortable symptoms of bacterial prostatitis. Pain relievers such as acetaminophen (Tylenol) and nonsteroidal anti-inflammatory drugs like ibuprofen (Advil, Motrin) or naproxen (Aleve) can reduce pelvic pain, fever, and general discomfort.

Medications called alpha-adrenergic blockers or simply alpha blockers can help relieve urinary symptoms. These drugs, including tamsulosin (Flomax), work by relaxing the muscles in the prostate gland and bladder neck, making it easier to urinate. This is particularly helpful because the swollen, inflamed prostate can squeeze the urethra and block urine flow.

Some healthcare providers also prescribe urinary analgesics such as phenazopyridine to reduce burning and pain during urination. Stool softeners may be recommended as well, since straining during bowel movements can worsen prostate pain.

Duration and Monitoring of Treatment

For acute bacterial prostatitis treated on an outpatient basis, the standard antibiotic course lasts four to six weeks. However, research has shown that the best long-term results often come from a twelve-week course of treatment, though patient compliance can be challenging with such extended therapy.

If symptoms return after an initial course of antibiotics, doctors may prescribe a second four-to-six-week course, often combined with an alpha blocker to help with urinary symptoms. Patients who do not respond well to initial treatment or who experience recurrent infections should be referred to a urologist, a specialist in urinary and reproductive system disorders.

Follow-up appointments are essential to ensure the infection has been completely cleared. Healthcare providers may repeat urine cultures after treatment ends to confirm that bacteria are no longer present. Blood tests that measure prostate-specific antigen (PSA), a protein produced by the prostate, may show elevated levels during infection but should gradually return to normal as the infection clears, though this process can take three to six months.

Possible Side Effects of Treatment

Like all medications, antibiotics used to treat bacterial prostatitis can cause side effects. Fluoroquinolones may cause nausea, diarrhea, headache, or dizziness in some patients. More rarely, they can affect tendons, potentially causing tendon inflammation or rupture, particularly in older adults or those taking corticosteroids. Some people may experience changes in blood sugar levels or develop sensitivity to sunlight while taking these medications.

Alpha blockers can cause dizziness, especially when standing up quickly, due to their effect on blood pressure. Some men may experience nasal congestion, headache, or fatigue. These medications can also affect ejaculation, sometimes causing a condition called retrograde ejaculation where semen enters the bladder instead of exiting through the penis.

It's important to discuss any side effects with your healthcare provider rather than simply stopping medications on your own. Often, adjusting the dose or switching to a different medication can resolve side effect issues while still effectively treating the infection.

Supportive Care Measures

In addition to medications, several self-care strategies can help manage symptoms and support recovery. Taking warm baths, sometimes called sitz baths, can help soothe pelvic pain and discomfort. Drinking plenty of fluids helps flush bacteria from the urinary system, though men with certain medical conditions like kidney, heart, or liver disease should consult their doctor before increasing fluid intake.

Avoiding alcohol, caffeine, and spicy or acidic foods can reduce irritation of the bladder and prostate. Acidic foods include tomato-based products and citrus fruits or juices. Urinating often and completely helps prevent bacteria from lingering in the urinary tract.

Managing Urinary Retention

In severe cases of acute bacterial prostatitis, the swollen prostate can completely block urine flow, a condition called urinary retention. This is a medical emergency requiring immediate treatment. When a man cannot urinate at all, a thin tube called a catheter must be inserted to drain the bladder.

Healthcare providers often prefer placing a suprapubic catheter, which is inserted through the lower abdomen directly into the bladder, rather than a catheter through the urethra. This approach is considered safer because threading a catheter through the infected, swollen prostate could potentially spread bacteria into the bloodstream. The catheter remains in place until the swelling subsides enough for normal urination to resume.

Treatment in Clinical Trials

While the sources provided do not contain specific information about experimental treatments or clinical trials for bacterial prostatitis, the standard antibiotic-based approaches described above represent well-established, evidence-based treatment protocols recommended by medical societies and widely used in clinical practice.

Most research in this field focuses on optimizing existing antibiotic regimens, understanding antibiotic resistance patterns, and developing better strategies for preventing and managing chronic or recurrent infections. Healthcare providers continue to study which antibiotic durations work best, how to manage treatment failures, and whether combining different medication classes improves outcomes.

Most common treatment methods

  • Fluoroquinolone antibiotics
    • Ciprofloxacin and levofloxacin are the most commonly prescribed antibiotics for bacterial prostatitis
    • These medications work by interfering with bacterial DNA to kill infection-causing bacteria
    • Typically prescribed for two to six weeks for acute infections, sometimes up to twelve weeks for chronic infections
    • Can penetrate prostate tissue effectively to reach the site of infection
  • Intravenous antibiotic therapy
    • Used for severe acute bacterial prostatitis requiring hospitalization
    • Common IV antibiotics include ceftriaxone with doxycycline, or piperacillin/tazobactam
    • Allows rapid delivery of high concentrations of antibiotics to the bloodstream
    • Continued until patient stabilizes, then switched to oral antibiotics
  • Alpha-adrenergic blocking medications
    • Medications like tamsulosin (Flomax) help relax muscles in the prostate and bladder neck
    • Make urination easier by reducing obstruction from the swollen prostate
    • Often used in combination with antibiotics, especially for chronic or recurrent infections
    • May help reduce recurrence of symptoms
  • Pain and symptom management
    • Over-the-counter pain relievers such as acetaminophen, ibuprofen, or naproxen
    • Urinary analgesics like phenazopyridine to reduce burning during urination
    • Warm baths to soothe pelvic pain
    • Stool softeners to prevent straining that can worsen prostate pain
  • Catheterization for urinary retention
    • Suprapubic or urethral catheter placement when the prostate blocks urine flow completely
    • Suprapubic catheters inserted through the abdomen are often preferred to avoid spreading infection
    • Temporary measure until swelling subsides and normal urination can resume

Did you know?

  1. More than two million men visit doctors annually for prostatitis symptoms, yet bacterial causes account for less than ten percent of all prostatitis cases, making bacterial prostatitis relatively uncommon compared to other prostate conditions.
  2. After procedures like transrectal prostate biopsy, the risk of developing bacterial prostatitis increases, and these infections are more likely to involve unusual bacteria like Pseudomonas or mixed organisms that may be harder to treat.
  3. Prostate fluid is essential for male fertility, and the prostate must produce this fluid even while infected, which is one reason why antibiotics must penetrate prostate tissue so effectively to clear bacterial infections.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Bacterial prostatitis

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ciprofloxacin
  • Sponsor:UZ Brussel
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cefixime
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Bacterial prostatitis+1

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin
  • Sponsor:Fundacio Assistencial De Mutua De Terrassa Fpc
See all 3 trials →filters applied: condition = Bacterial prostatitis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).